Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 132 for

Edit search filters
  1. A Study To Compare The Rate Of Major Cardiovascular Implantable Electronic Device Infections With The Absorbable Antibacterial Envelope And Without

    Rochester, MN

  2. Pragmatic Study Of Disparities In Chronic Disease Approach To Ameliorate Tobacco Related Cardiovascular Disease

    Rochester, MN

  3. TOCCASTAR - TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation

  4. Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease

    Rochester, MN

  5. A Study Comparing Apixaban To Vitamin K Antagonist For The Prevention Of Stroke Or Systemic Embolism And Bleeding In Patients With Non-valve Atrial Fibrillation And Acute Coronary Syndrome Or Percutaneous Coronary Intervention

    Scottsdale/Phoenix, AZ

  6. Improving Wellbeing in Ischemic Heart Disease

    Jacksonville, FL

  7. Continued Access To PREVAIL (CAP2)

    Rochester, MN

  8. Autologous Induced Pluripotent Stem Cells of Cardiac Lineage Delivered Into Heart Muscle for Congenital Heart Disease

    Rochester, MN

  9. A Study Validating The "Foods For Health" Portfolio Of Functional Food Products, For People Unable To Take Statin Drugs

    Rochester, MN

  10. The Ventilatory Response to Activation of the Locomotor Afferents in Normoxic and Hypoxic Conditions

    Rochester, MN

.

Mayo Clinic Footer